Author

Élysée Matungulu

Observed names: Elysee B Matungulu, Elysé Matungulu, Elysée Matungulu, Matungulu, Elysee B

Institution: National Institute of Biomedical Research

Observed institution: National Institute of Biomedical Research

OpenAlex ID: A5059650751

High Prevalence of Anti–Severe Acute Respiratory Syndrome Coronavirus 2 (Anti–SARS-CoV-2) Antibodies After the First Wave of Coronavirus Disease 2019 (COVID-19) in Kinshasa, Democratic Republic of the Congo: Results of a Cross-sectional Household-Based Survey

2021 · Antoine N Nkuba, Sheila M Makiala, et al. · Clinical Infectious Diseases · 51

Determinants of long-term SARS-CoV-2 immune responses in asymptomatic-to-moderate COVID-19 patients in sub-Saharan Africa

2026 · Víctor L. de Rioja, Odin Goovaerts, et al. · BMC Medicine · 3

Long-term antibody responses to the Ebola virus and the vaccine vector after rVSV-ZEBOV vaccination in DRC

2025 · Christian M. Kahusu, Laurène Peckeu-Abboud, et al. · Vaccine · 3

Corrigendum to “Long-term antibody responses to the Ebola virus and the vaccine vector after rVSV-ZEBOV vaccination in DRC” [Vaccine 62 (2025) 127537]

2025 · Christian M. Kahusu, Laurène Peckeu-Abboud, et al. · Vaccine

Revisiting a COVID-19 seroprevalence cohort survey among health care workers and their household members in Kinshasa, DR Congo, 2020-2022

2023 · Joule Madinga, Placide Mbala, et al. · Research Square

Seroprevalence and Seroreversion of SARS-CoV-2 Antibodies in a Cohort of Health Care Workers, Kinshasa, Democratic Republic of Congo

2022 · Joule Madinga, Placide Mbala, et al. · SSRN Electronic Journal

Works count: 7

Citation count: 66

H-index: 3

I10-index: 1